课题基金 / 基金详情

A COMPARISON OF TWO STRAINS OF E COLI TO PRODUCE SEPTIC SHOCK IN DOGS

A COMPARISON OF TWO STRAINS OF E COLI TO PRODUCE SEPTIC SHOCK IN DOGS
两种引起狗感染性休克的大肠杆菌菌株的比较
批准号:
6161407
负责人:
C NATANSON
金额:
$0.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

C NATANSON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Summary of Work: While live bacteria commonly cause infection, the relative role of bacterial toxins versus live bacteria to produce morbidity and mortality is not known. If bacterial toxins are important factors, therapies directed at these toxins may be required. Even if no bacteria remain alive or grow, these preformed toxins may be important in determining morbidity and mortality. Therapies directed at these toxins may be important additions to antibiotic therapy. Using two strains of Escherichia coli, a nonvirulent E. coli strain (O86;H8) and a virulent E. coli strain (O6;Hl;K2), in the canine model, we designed a study to determine whether organism virulence factors or bacterial toxins were more important in producing septic shock. Measures of hemodynamic shock, blood cultures, endotoxin levels, and survival were done serially with both organisms live, both organisms killed, and with purified endotoxin from these organisms. Preliminary results from these studies have been presented to the American Federation of Clinical Research and the Society of Critical Care Medicine. The results suggested that virulence factors are much more important than preformed endotoxins for the development of endotoxemia. To further address this issue, we are collaborating with Tom Russo of LCI, MAID, and more recently the University of Buffalo, to examine the role of endotoxin as a virulence factor within the same of E. coli. We are using a gene disruption technique to produce an E. Coli strain with a deficiency in endotoxin O type side chains (another virulence factor). This will further explore the relative role of endotoxin in septic shock. Much work is presently being done to target this pathogen in human septic shock. There has been much interest in these results because the determination of the factors that produce morbidity in infection will guide trials for future therapies for children and adults with septic shock.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
USE OF A SELECTIVE BRADYKININ ANTAGONIST IN A CANINE MODEL OF SEPTIC SHOCK
  • 批准号:
    5201091
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    C NATANSON
  • 依托单位:
NITRIC OXIDE SYNTHASE INHIBITORS IN VIVO TNF-INDUCED MYOCARDIAL DEPRESSION
  • 批准号:
    3752179
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    C NATANSON
  • 依托单位:
INVESTIGATIONS OF NEW THERAPIES IN SEPTIC SHOCK
  • 批准号:
    3874266
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    C NATANSON
  • 依托单位:
A COMPARISON OF STRAINS OF E. COLI TO PRODUCE SEPTIC SHOCK IN DOGS
  • 批准号:
    3853021
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    C NATANSON
  • 依托单位:
海外基金